Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED) [Phase 3]
A Phase 3 trial for elderly patients with primary insomnia was terminated, with the study using polysomnography to assess outcomes.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED) [Phase 3]
A Phase 3 cross-over study evaluating adult polysomnography for primary insomnia sponsored by H. Lundbeck A/S has been terminated.
-
CLINICAL_TRIALS withdrawal · 2015-01-14Clinical Trial Update: An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007) [Phase 3]
A Phase 3 clinical trial studying an investigational drug for insomnia in healthy adult volunteers was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED) [Phase 2]
Phase 2 sleep study of MK0928 in adults with primary insomnia has been terminated. This is a status update for the trial.
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders [NA]
The study reports results from a completed clinical trial evaluating an internet-based therapy for chronic insomnia in veterans with substan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-02FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for zolpidem tartrate filed by Sandoz Inc., authorizing changes to an existing zolpidem tartrate…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Online or Face-to-face Treatment for Insomnia? [Phase 3]
A Phase 3 trial evaluating online versus face-to-face treatment for insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Treating Sleep Problems in VA Adult Day Health Care [NA]
Completed VA clinical trial evaluating treatments for insomnia and sleep disorders; results were posted in December 2014.
-
FDA approval · 2014-12-24FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for zolpidem tartrate by Torrent Pharmaceuticals Limited, authorizing a generic formulation for …
-
FDA approval · 2014-12-22FDA Approved: ESZOPICLONE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Eszopiclone from Teva Pharmaceuticals USA, Inc., related to the approved product.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Polysomnographic Study to Compare the Efficacy of Gastric Retentive Zaleplon Accordion Pill to Placebo in Subjects With Insomnia [Phase 2]
Phase 2 trial update comparing a gastric-retentive zaleplon accordion-pill to placebo in adults with insomnia; the study has completed.
-
CLINICAL_TRIALS research · 2014-12-17Clinical Trial Update: Evaluating Neuromodulation Technologies in Early Recovery [NA]
Clinical trial update on neuromodulation technologies being evaluated for early recovery, with conditions including Depression, Anxiety diso…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance [Phase 4]
Phase 4 trial from Duke University evaluating a melatonin receptor agonist on sleep latency and inflammation/insulin resistance in insomnia;…
-
FDA approval · 2014-12-05FDA Approved: ESZOPICLONE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for eszopiclone. This action represents a supplemental approval for t…
-
FDA approval · 2014-12-05FDA Approved: ESZOPICLONE — Supplemental Application (Glenmark Pharmaceuticals Inc. USA)
The FDA approved a supplemental application for eszopiclone submitted by Glenmark Pharmaceuticals Inc. USA.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Trial on the Effect of Optically Modified Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain [NA]
A completed clinical trial evaluated whether optically modified fiber mattress covers reduce sleep disturbances in patients with chronic bac…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Effects of Peer Support and Yoga Music on T2DM With Depression and Sleep Disorders [NA]
This entry reports the completion of a clinical trial evaluating the effects of peer support and yoga music on adults with type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities [Phase 3]
Phase 3 clinical trial evaluating melatonin to improve sleep in children with epilepsy and neurodevelopmental disabilities has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients [Phase 2]
This is a Phase 2 pilot study testing cyclobenzaprine for sleep disturbances in aromatase inhibitor-treated breast cancer patients, which wa…
-
CLINICAL_TRIALS trial_result · 2014-11-17Clinical Trial Update: Examining the Effect of Acupuncture on Sleep Difficulties Related to Post Traumatic Stress Disorder [NA]
A VA-sponsored clinical trial examined acupuncture as a treatment for sleep difficulties related to post-traumatic stress disorder, with res…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006) [Phase 2]
Phase IIB 2-period crossover polysomnography study of MK-4305-006 in adults with primary insomnia completed; results posted in 2014.
-
FDA approval · 2014-11-07FDA Approved: BELSOMRA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for BELSOMRA (suvorexant) from Merck Sharp & Dohme LLC, resulting in an updated labeling for the…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Eszopiclone Treatment & Cortisol Responsivity [Phase 4]
Phase 4 trial evaluating eszopiclone for insomnia with cortisol responsivity outcomes; study completed and results posted in 2014.
-
FDA approval · 2014-11-03FDA Approved: LUNESTA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lunesta (eszopiclone) from Waylis Therapeutics LLC. The action involves changes to Lunesta's…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: Modafinil Treatment for Sleep/Wake Disturbances in Older Adults [Phase 4]
Phase 4 trial evaluating modafinil for sleep/wake disturbances in older adults; terminated with results posted in 2014.